Patents by Inventor Joseph Fahey

Joseph Fahey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and apparatus for cooling of chips using a plurality of customized thermally conductive materials
    Patent number: 5724729
    Abstract: The present invention relates generally to a new apparatus and method for customized cooling of chips using a plurality of thermally conductive materials. More particularly, the invention encompasses an apparatus and a method that provides customized cooling of a MCM (Multi-Chip Module) by using a plurality of thermally conductive materials.
    Type: Grant
    Filed: April 15, 1996
    Date of Patent: March 10, 1998
    Assignee: International Business Machines Corporation
    Inventors: Raed A. Sherif, Mark Gerard Courtney, David Linn Edwards, Albert Joseph Fahey, Gregory Scott Hopper, Sushumna Iruvanti, Charles Frederick Jones, Gaetano Paolo Messina
  • Heterocyclic substituted benzothiophenes, compositions, and methods
    Patent number: 5688796
    Abstract: The present invention provides class of compounds of formula I ##STR1## and their pharmaceutically acceptable salts in which R.sup.1 is hydrogen, hydroxy, alkoxy, alkoxycarbonyloxy, alkylcarbonyloxy, arylcarbonyloxy; R.sup.2 is hydrogen, hydroxy, alkoxy, alkoxycarbonyloxy, alkylcarbonyloxy, alkylsulfonyloxy, arylcarbonyloxy, Cl or Br; R.sup.3 and R.sup.4 are independently C.sub.1 -C.sub.4 alkyl, or combine with the nitrogen atom to which they are attached to form a pyrrolidino, piperidino, or hexamethyleneimino ring; X is selected from ##STR2## and Y is --CO--, --CHOH--, or --CH.sub.2 --. The compounds and pharmaceutical compositions containing the compounds, either alone or in combination with either progestin or estrogen, are useful for alleviating the symptoms of osteoporosis, cardiovascular related pathological conditions such as hyperlipidemia, and estrogen-dependent cancer.
    Type: Grant
    Filed: February 7, 1997
    Date of Patent: November 18, 1997
    Assignee: Eli Lilly and Company
    Inventors: George Joseph Cullinan, Kennan Joseph Fahey